FDA Approved: FEBUXOSTAT — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for febuxostat filed by Zydus Lifesciences Limited under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

SUPPL AP for FEBUXOSTAT (FEBUXOSTAT)